» Authors » Ekaterina Mikhailova

Ekaterina Mikhailova

Explore the profile of Ekaterina Mikhailova including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 72
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Semchenkova A, Mikhailova E, Demina I, Roumiantseva J, Karachunskiy A, Novichkova G, et al.
Int J Mol Sci . 2025 Mar; 26(5). PMID: 40076625
Multicolor flow cytometry (MFC) is a key method for assessing measurable residual disease (MRD) in acute lymphoblastic leukemia (ALL). However, very few approaches were developed for MRD in T-cell ALL...
2.
Mikhailova E, Popov A, Roumiantseva J, Budanov O, Lagoyko S, Zharikova L, et al.
J Immunother Cancer . 2024 Jun; 12(6). PMID: 38844406
The bispecific T cell-binding antibody blinatumomab (CD19/CD3) is widely and successfully used for the treatment of children with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Here, we report...
3.
Demina I, Mikhailova E, Zerkalenkova E, Semchenkova A, Roumiantseva J, Borkovskaya A, et al.
Am J Clin Pathol . 2024 Mar; 162(2):180-190. PMID: 38513276
Objectives: Mixed-phenotype acute leukemia (MPAL) is a rare disease associated with difficulties in the correct lineage assignment of leukemic cells. One of the least common subtypes within this category is...
4.
Zerkalenkova E, Menchits Y, Borkovskaia A, Sokolova S, Soldatkina O, Mikhailova E, et al.
Int J Lab Hematol . 2023 Apr; 45(4):533-540. PMID: 37058324
Introduction: B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is the most common neoplasm in children. One of the long known recurrent rearrangements in BCP-ALL is t(1;19)(q23;p13.3)/TCF3::PBX1. However, other TCF3 gene rearrangements...
5.
Borkovskaia A, Bogacheva S, Konyukhova T, Dadakhanova E, Gaskova M, Soldatkina O, et al.
Genes (Basel) . 2023 Mar; 14(3). PMID: 36980947
Acute promyelocytic leukemia (APL) pathogenesis is based on gene translocations, which are of high importance in the diagnosis of and proper therapy selection for APL. However, in some cases acute...
6.
Semchenkova A, Zhogov V, Zakharova E, Mikhailova E, Illarionova O, Larin S, et al.
Int J Lab Hematol . 2023 Mar; 45(4):506-515. PMID: 36871952
Introduction: Multicolor flow cytometry (MFC) has highly reliable and flexible algorithms for diagnosis and monitoring of acute lymphoblastic leukemia (ALL). However, MFC analysis can be affected by poor sample quality...
7.
Mikhailova E, Illarionova O, Komkov A, Zerkalenkova E, Mamedov I, Shelikhova L, et al.
Cancers (Basel) . 2022 Nov; 14(21). PMID: 36358863
We aimed to develop an antibody panel and data analysis algorithm for multicolor flow cytometry (MFC), which is a reliable method for minimal residual disease (MRD) detection in patients with...
8.
Mikhailova E, Itov A, Zerkalenkova E, Roumiantseva J, Olshanskaya Y, Karachunskiy A, et al.
Cytometry B Clin Cytom . 2022 Jul; 102(5):353-359. PMID: 35796438
Background: The potential loss of CD19 during targeted treatment of B cell precursor acute lymphoblastic leukemia (BCP-ALL) can hamper flow cytometric minimal residual disease (MRD) monitoring. In the current study,...
9.
Semchenkova A, Mikhailova E, Komkov A, Gaskova M, Abasov R, Matveev E, et al.
Int J Mol Sci . 2022 Apr; 23(7). PMID: 35409391
We report incidence and deep molecular characteristics of lineage switch in 182 pediatric patients affected by B-cell precursor acute lymphoblastic leukemia (BCP-ALL), who were treated with blinatumomab. We documented six...
10.
Popov A, Tsaur G, Verzhbitskaya T, Riger T, Permikin Z, Demina A, et al.
Br J Haematol . 2021 Dec; 201(3):510-519. PMID: 34970734
This study aimed to evaluate the concordance between minimal residual disease (MRD) results obtained by multicolour flow cytometry (MFC) and polymerase chain reaction for fusion gene transcripts (FGTs) in infants...